National Quality Measures Clearinghouse | Venous thromboembolism (VTE): The Joint Commission.

The Joint Commission

1.- Venous thromboembolism (VTE): percent of patients diagnosed with confirmed VTE during hospitalization (not present on arrival) who did not receive VTE prophylaxis between hospital admission and the day before the VTE diagnosis testing order date. This updates a previously published measure summary.

full-text:
National Quality Measures Clearinghouse | Venous thromboembolism (VTE): percent of patients diagnosed with confirmed VTE during hospitalization (not present on arrival) who did not receive VTE prophylaxis between hospital admission and the day before the VTE diagnosis testing order date.




2.- Venous thromboembolism (VTE): percent of patients diagnosed with confirmed VTE that are discharged to home, to home with home health or home hospice, or discharged/transferred to court/law enforcement on warfarin with written discharge instructions that address all four criteria: compliance issues, dietary advice, follow-up monitoring, and information about the potential for adverse drug reactions/interactions. This updates a previously published measure summary.

full-text:
National Quality Measures Clearinghouse | Venous thromboembolism (VTE): percent of patients diagnosed with confirmed VTE that are discharged to home, to home with home health or home hospice, or discharged/transferred to court/law enforcement on warfarin with written discharge instructions that address all four criteria: compliance issues, dietary advice, follow-up monitoring, and information about the potential for adverse drug reactions/interactions.




3.- Venous thromboembolism (VTE): percent of patients diagnosed with confirmed VTE who received an overlap of parenteral (intravenous or subcutaneous) anticoagulation and warfarin therapy. This updates a previously published measure summary.

full-text:
National Quality Measures Clearinghouse | Venous thromboembolism (VTE): percent of patients diagnosed with confirmed VTE who received an overlap of parenteral (intravenous or subcutaneous) anticoagulation and warfarin therapy.




4.- Venous thromboembolism (VTE): percent of patients diagnosed with confirmed VTE who received intravenous unfractionated heparin therapy dosages AND had their platelet counts monitored using defined parameters such as a nomogram or protocol. This updates a previously published measure summary.

full-text:
National Quality Measures Clearinghouse | Venous thromboembolism (VTE): percent of patients diagnosed with confirmed VTE who received intravenous unfractionated heparin therapy dosages AND had their platelet counts monitored using defined parameters such as a nomogram or protocol.




5.- Venous thromboembolism (VTE): percent of patients who received VTE prophylaxis or have documentation why no VTE prophylaxis was given the day of or the day after hospital admission or surgery end date for surgeries that start the day of or the day after hospital admission. This updates a previously published measure summary.

full-text:
National Quality Measures Clearinghouse | Venous thromboembolism (VTE): percent of patients who received VTE prophylaxis or have documentation why no VTE prophylaxis was given the day of or the day after hospital admission or surgery end date for surgeries that start the day of or the day after hospital admission.



6.- Venous thromboembolism (VTE): percent of patients who received VTE prophylaxis or have documentation why no VTE prophylaxis was given the day of or the day after initial admission (or transfer) to the intensive care unit (ICU) or surgery end date for surgeries that start the day of or the day after ICU admission (or transfer). This updates a previously published measure summary.

full-text:
National Quality Measures Clearinghouse | Venous thromboembolism (VTE): percent of patients who received VTE prophylaxis or have documentation why no VTE prophylaxis was given the day of or the day after initial admission (or transfer) to the intensive care unit (ICU) or surgery end date for surgeries that start the day of or the day after ICU admission (or transfer).